The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 84-90 , July 2007

Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood

  • Gary M. Hunninghake, MD

      Affiliations

    • From the Channing Laboratory
    • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston
    • Department of Medicine, Harvard Medical School, Boston
    • ,
  • Manuel E. Soto-Quirós, MD, PhD

      Affiliations

    • Division of Pediatric Pulmonology, Hospital Nacional de Niños, San José
    • ,
  • Lydiana Avila, MD

      Affiliations

    • Division of Pediatric Pulmonology, Hospital Nacional de Niños, San José
    • ,
  • Jessica Su, PhD

      Affiliations

    • From the Channing Laboratory
    • Department of Biostatistics, Harvard School of Public Health, Boston
    • ,
  • Amy Murphy, PhD

      Affiliations

    • From the Channing Laboratory
    • Department of Biostatistics, Harvard School of Public Health, Boston
    • ,
  • Dawn L. Demeo, MD, MPH

      Affiliations

    • From the Channing Laboratory
    • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston
    • Department of Medicine, Harvard Medical School, Boston
    • ,
  • Ngoc P. Ly, MD, MPH

      Affiliations

    • From the Channing Laboratory
    • Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Massachusetts General Hospital for Children and Harvard Medical School, Boston
    • ,
  • Catherine Liang, MPH

      Affiliations

    • From the Channing Laboratory
    • ,
  • Jody S. Sylvia, BS

      Affiliations

    • From the Channing Laboratory
    • ,
  • Barbara J. Klanderman, PhD

      Affiliations

    • From the Channing Laboratory
    • Department of Medicine, Harvard Medical School, Boston
    • ,
  • Christoph Lange, PhD

      Affiliations

    • Department of Biostatistics, Harvard School of Public Health, Boston
    • ,
  • Benjamin A. Raby, MDCM, MPH

      Affiliations

    • From the Channing Laboratory
    • Department of Medicine, Harvard Medical School, Boston
    • Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Boston
    • ,
  • Edwin K. Silverman, MD, PhD

      Affiliations

    • From the Channing Laboratory
    • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston
    • Department of Medicine, Harvard Medical School, Boston
    • ,
  • Juan C. Celedón, MD, DrPH

      Affiliations

    • From the Channing Laboratory
    • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston
    • Department of Medicine, Harvard Medical School, Boston
    • Corresponding Author InformationReprint requests: Juan C. Celedón, MD, DrPH, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115.

Received 23 March 2007 ,Revised 23 April 2007 ,Accepted 24 April 2007.

References 

  1. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258–2261
  2. McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A. 1993;90:3735–3739
  3. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol. 2005;174:1063–1072
  4. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 2003;9:582–588
  5. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993;90:3730–3734
  6. Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL, et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax. 2006;61:202–208
  7. Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, et al. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. Chest. 2005;128:1921–1927
  8. Bogdan C, Thuring H, Dlaska M, Rollinghoff M, Weiss G. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol. 1997;159:4506–4513
  9. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003;300:1527–1528
  10. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem. 1996;271:16921–16926
  11. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12:99–106
  12. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, et al. Genetic susceptibility to asthma–bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. 1995;333:894–900
  13. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet. 1997;15:389–392
  14. Ober C, Cox NJ. The genetics of asthma: mapping genes for complex traits in founder populations. Clin Exp Allergy. 1998;28(suppl 1):101–105discussion 8-10
  15. Meyers DA, Postma DS, Panhuysen CI, Xu J, Amelung PJ, Levitt RC, et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics. 1994;23:464–470
  16. Bleecker ER, Amelung PJ, Levitt RC, Postma DS, Meyers DA. Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: a major regulatory locus important in asthma. Clin Exp Allergy. 1995;25(suppl 2):84–88discussion 95-6
  17. Postma DS, Meyers DA, Jongepier H, Howard TD, Koppelman GH, Bleecker ER. Genomewide screen for pulmonary function in 200 families ascertained for asthma. Am J Respir Crit Care Med. 2005;172:446–452
  18. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol. 2006;177:8633–8642
  19. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest. 2005;115:747–754
  20. Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T, et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol. 2002;109:980–987
  21. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 2000;9:549–559
  22. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT, et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol. 2001;25:377–384
  23. Hakonarson H, Bjornsdottir US, Ostermann E, Arnason T, Adalsteinsdottir AE, Halapi E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med. 2001;164:2036–2044
  24. Celedon JC, Soto-Quiros ME, Palmer LJ, Senter J, Mosley J, Silverman EK, et al. Lack of association between a polymorphism in the interleukin-13 gene and total serum immunoglobulin E level among nuclear families in Costa Rica. Clin Exp Allergy. 2002;32:387–390
  25. Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000;105:506–513
  26. DeMeo DL, Lange C, Silverman EK, Senter JM, Drazen JM, Barth MJ, et al. Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol. 2002;23:335–348
  27. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol. 2006;117:269–274
  28. Maier LM, Howson JM, Walker N, Spickett GP, Jones RW, Ring SM, et al. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol. 2006;117:1306–1313
  29. Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam CW. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy. 2001;31:1515–1521
  30. Hunninghake GM, Soto-Quiros ME, Avila L, Ly NP, Liang C, Sylvia JS, et al. Sensitization to Ascaris lumbricoides and severity of childhood asthma in Costa Rica. J Allergy Clin Immunol. 2007;119:654–661
  31. Blumenthal MN, Banks-Schlegel S, Bleecker ER, Marsh DG, Ober C. Collaborative studies on the genetics of asthma: National Heart, Lung and Blood Institute. Clin Exp Allergy. 1995;25(suppl 2):29–32
  32. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107–1136
  33. Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS. A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis. 1982;126:235–240
  34. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. Control Clin Trials. 1999;20:91–120
  35. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med. 2000;343:1054–1063
  36. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′—3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88:7276–7280
  37. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259–266
  38. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  39. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO, et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999;1:61–65
  40. Moissidis I, Chinoy B, Yanamandra K, Napper D, Thurmon T, Bocchini J, et al. Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genet Med. 2005;7:406–410
  41. He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 2003;4:385–389
  42. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. PBAT: tools for family-based association studies. Am J Hum Genet. 2004;74:367–369
  43. Freely associating. Nat Genet. 1999;22:1–2
  44. Minor TE, Dick EC, DeMeo AN, Ouellette JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. JAMA. 1974;227:292–298
  45. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston S, et al. A study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospitalization in children. Thorax. 2006;61:376–382
  46. Gern JE, Brooks GD, Meyer P, Chang A, Shen K, Evans MD, et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol. 2006;117:72–78
  47. Zhou W, Hashimoto K, Moore ML, Elias JA, Zhu Z, Durbin J, et al. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse. Microbes Infect. 2006;8:2880–2889
  48. Sorkness RL, Gern JE, Grindle KA, Mosser AG, Rosenthal LA, Mikus LD, et al. Persistence of viral RNA in 2 rat strains differing in susceptibility to postbronchiolitis airway dysfunction. J Allergy Clin Immunol. 2002;110:607–609
  49. Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis. 2006;193:438–441
  50. Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol. 2007;119:1086–1091
  51. Eum SY, Maghni K, Hamid Q, Eidelman DH, Campbell H, Isogai S, et al. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol. 2003;111:1049–1061
  52. Gibbons FK, Israel E, Deykin A, Schaub B, He HZ, Perkins DL, et al. The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretion. J Clin Immunol. 2005;25:437–444

 Supported by grants HL04370 and HL66289 from the National Institutes of Health. The CAMP Genetics Ancillary Study is supported by the National Heart, Lung, and Blood Institute, N01-HR-16049. Additional support for this research came from grants P50 HL67664 and T32 HL07427 from the National Institutes of Health and the National Heart, Lung, and Blood Institute.Disclosure of potential conflict of interest: E. K. Silverman has consulting arrangements with GlaxoSmithKline; has received grant support from GlaxoSmithKline; has received money for a talk on chronic obstructive pulmonary disease genetics from Wyeth; and has received honoraria from Bayer. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)00858-5

doi: 10.1016/j.jaci.2007.04.032

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 84-90 , July 2007

Article Tools